Corporate insider profile
Octavio Espinoza Insider Trades
Octavio Espinoza has reported no open-market purchases on SEC Form 4 and is a net seller of $9,241,229 across 1 company. The most recent open-market transaction was reported on Aug 12, 2026. Source: SEC Form 4 filings.
Latest reported as Chief Financial Officer of LIGAND PHARMACEUTICALS INC (LGND).
SEC-reported filing activity is provided for research purposes and is not investment advice.
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$9,241,228.67
- Latest transaction
- Aug 12, 2026
Affiliated corporations
Reported company relationships
Transaction history
Open-market Transactions
Common questions
Octavio Espinoza insider trading FAQ
- Is Octavio Espinoza buying or selling stock?
- Across all SEC Form 4 open-market filings on record, Octavio Espinoza is a net seller of $9,241,229, with no open-market purchases reported. The latest transaction was reported on Aug 12, 2026.
- Which companies does Octavio Espinoza report insider trades for?
- Octavio Espinoza has reported open-market trades in LIGAND PHARMACEUTICALS INC (LGND). The latest SEC-reported relationship is Chief Financial Officer of LIGAND PHARMACEUTICALS INC (LGND).
- Where does Octavio Espinoza's insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1905248, and refreshes this page daily.
